Abstract: A regular octahedral iron phosphate, a preparation method thereof, a lithium iron phosphate cathode material, and a lithium iron phosphate battery are disclosed. The method for preparing the regular octahedral iron phosphate includes: obtaining a mixed solution A containing a phosphate and a ferrous salt, in which, the mixed solution A is an acidic solution; mixing the mixed solution A with an oxidant, during which, ferrous ions in the mixed solution A are oxidized into ferric ions, whereby obtaining a slurry A; mixing the slurry A with a phosphoric acid solution and enabling reaction under a heating condition, whereby obtaining a slurry B; and subjecting the slurry B to solid-liquid separation treatment, washing treatment, drying treatment, and calcination treatment, whereby obtaining the regular octahedral iron phosphate.

Abstract: The present invention relates to a compound represented by general formula (I) or a stereoisomer, deuterated compound, solvate, prodrug, metabolite, pharmaceutically acceptable salt or eutectic crystal thereof, and an intermediate thereof, and use thereof in IRAK4-related diseases such as an autoimmune disease, an inflammatory disease or cancer.

Abstract: A display panel, a method for manufacturing a display panel, and a display apparatus. The display panel includes a display region, a non-display region at least partially surrounding the display region, and further includes a base plate, a wiring layer, a light-emitting layer, and an isolation structure. The wiring layer is located on a side of the base plate and includes a metal layer located in the display region and a signal line layer located in the non-display region. The light-emitting layer is located on a side of the wiring layer away from the base plate and includes a plurality of light-emitting units. The isolation structure is located on a side of the wiring layer away from the base plate and is provided with an isolation opening configured to accommodate the light-emitting unit.

Abstract: A method for detecting airbag deployment includes operating a plurality of sensors of the mobile device disposed in a vehicle during a drive to obtain a plurality of measurement signals, determining a change in at least one measurement signal of the plurality of measurement signals and that the change exceeds a first threshold. In response to determining that the change exceeds the first threshold, obtaining a pressure measurement signal from a pressure sensor of the plurality of sensors, determining a derivative of the pressure measurement signal, and determining that the derivative of the pressure measurement signal exceeds a second threshold. In response to determining that the derivative of the pressure measurement signal exceeds the second threshold, detecting a deployment of a vehicle airbag based on the change in the at least one measurement signal exceeding the first threshold and the derivative of the pressure measurement signal exceeding the second threshold.

Abstract: The present application discloses an intestine-targeted drug delivery composition, comprising in sequence, from inside to outside, (1) a microsphere core and a pH-independent sustained-release layer containing an active ingredient, or a microsphere containing an active ingredient and a pH-independent sustained-release layer, or a microsphere containing an active ingredient and a pH-independent sustained-release material, (2) a pH-dependent coating layer, and (3) a time-dependent pulsatile controlled-release layer. The intestine-targeted drug delivery composition of the present application delivers the active ingredient to intestinal tissues (especially colon tissue) for release, reduces the systemic blood concentration of the active ingredient, and improves the pharmacokinetic characteristics and concentration of the active ingredient in intestinal tissues. The composition is suitable for treating intestinal diseases, such as inflammatory bowel diseases including Crohn's disease and ulcerative colitis.

Abstract: A treatment method and a cleaning apparatus for an implant treated with a reagent arc disclosed. The cleaning apparatus for treating an implant treated with a reagent includes: a base; a rotatable rack for placing one or more implants; and a driving mechanism coupled with the rotatable rack.

Abstract: An apparatus and a method for testing a multi-channel high-speed low-latency interconnect interface (HLII) for a silicon interposer are provided. The apparatus includes: a standard test port configured to exchange a test instruction; an asynchronous bypass port configured to directly access an input/output (I/O) port of a channel of a physical layer of the interconnection interface; a built-in self-test (BIST) engine configured to implement inter-level loopback testing and data verification; a redundant data channel configured to repair a damaged data channel; and a delay chain testing circuit configured to test a function and linearity of a delay chain. The apparatus embeds test and repair logic into the physical layer and a link layer, achieving internal test control without any external controller. In this way, a sample can be tested and quickly screened to ensure its performance.

Abstract: Data queries that are agnostic to any particular data source may include a data source alias. The data source alias may be replaced with a data source identifier to obtain a data query configured for a target data source. Data processing jobs may be agnostic to any particular data processing platform. A data processing job may include a data processing task that is agnostic to any particular data processing platform. A code library may provide platform-specific code configured to implement a data processing task on a data processing platform. A data query configured for a particular data source and a data processing task configured for a particular data processing platform may be used to create a data processing job. Configurations that restrict execution of a data processing job to execution via an interactive development environment may be removed to allow its execution directly at the data processing platform itself.

Abstract: A shareable battery pack for a portable ultrasonic apparatus, a trolley, a power supply system, and a portable ultrasonic system. The trolley can be connected to the portable ultrasonic apparatus and/or the shareable battery pack to supply power so as to extend operation time. Alternatively, the trolley is used to support the portable ultrasonic apparatus and/or the shareable battery pack without supplying power to extend operation time. In an embodiment, the shareable battery pack can be removed from the trolley, and then be fixedly connected to the portable ultrasonic apparatus to form an integral unit and serve as an external battery for the portable ultrasonic apparatus. Such design enables the portable ultrasonic apparatus to have extended operation time without relying on the trolley and requires only one shareable battery pack in special situations, thereby enhancing convenience of use.

Abstract: A time-sensitive network control system and a centralized network configuration entity for controlling data traffic in the time-sensitive network control system.

Abstract: The present invention relates to the technical field of medicinal chemistry, and particularly to a method for preparing a 3-tetrazolylmethyl-1,3,5-triazin-2,4-dione compound inhibiting coronavirus 3CL protease activity and use thereof. Specifically, a compound of Formula I, or a pharmaceutically acceptable salt, or an optical isomer, or an isotope-substituted form thereof is provided. The compound effectively inhibits the SARS-CoV-2 3CLpro activity, and is useful in the preparation of a SARS-CoV-2 3CLpro inhibitor to block the replication and transcription of SARS-CoV-2 viruses in patients. The compound prepared in the present invention has high in-vitro safety, and very good prospect of application in the preparation of SARS-CoV-2 3CLpro inhibitors and anti-SARS-CoV-2 drugs.

Abstract: An isolated protein comprising a mutant soluble activin II receptor (ActRIIA or ActRIIB) extracellular domain (Ac-tRIIA-ECD or ActRIIB-ECD), wherein said mutant soluble ActRIIA-ECD or ActRIIB-ECD comprises a mutation to remove the N-linked glycosylation site corresponding to position N18 of SEQ ID NO: 1.

Abstract: A system for retail forecasting and task management. The system includes a sales history database storing sales histories associated with a plurality of store locations; a network adapter; and a control circuit. The control circuit is configured to: provide, via the network adapter, a retail task user interface on a user device at a store location; cluster a plurality of store locations based on shared characteristics; determine a local sales forecast value on a future date for the store location based on a sales history of the store location using a first forecast model; determine a group sales forecast value on the future date based on sales histories of other store locations using the first forecast model; determine an adjusted sales forecast for the store location based on the local sales forecast value and the group sales forecast value; and provide the adjusted sales forecast.

Abstract: An accelerator architecture is presented for a Transformer machine learning model. The accelerator is comprised of: one or more memory devices, each memory device has a random access memory and is configured for processing in memory, where a key matrix, a value matrix, a query weight matrix, a key weight matrix, and a value weight matrix for an attention mechanism of the Transformer machine learning model are stored in the one or more memory devices; and a control device interfaced with each of the one or more memory devices, the control device is used to coordinate the vector matrix multiplication operations performed on the memory devices, perform other arithmetic and logic operations used in attention blocks that are not suited for the memory devices, and coordinate the updates of the key and value matrices in the one or more memory devices.

Abstract: An integrated circuit (IC) with conductive structures and a method of fabricating the IC are disclosed. The method includes depositing a first dielectric layer on a semiconductor device, forming a conductive structure in the first dielectric layer, removing a portion of the first dielectric layer to expose a sidewall of the conductive structure, forming a barrier structure surrounding the sidewall of the conductive structure, depositing a conductive layer on the barrier structure, and performing a polishing process on the barrier structure and the conductive layer.

Abstract: A method for providing steering assist for a vehicle includes determining whether a primary communication system of the vehicle communicated a first vehicle speed signal, the first vehicle speed signal indicating a first vehicle speed of the vehicle. The method also includes, in response to a determination that the primary communication system did not communicate the first vehicle speed signal, detecting a fault in the primary communication system. The method also includes, in response to detecting the fault in the primary communication system, determining whether a secondary communication system communicated a second vehicle speed signal, the second vehicle speed signal indicating a second vehicle speed of the vehicle. The method also includes, in response to a determination that the secondary communication system communicated the second vehicle speed signal, selectively providing steering assist to a steering mechanism of the vehicle based on the second vehicle speed of the vehicle.

Abstract: In some embodiments, a method sends a set of first requests for a set of first segments of a video in a playback session. A first protocol from a plurality of protocols is specified in at least one of the set of first requests. The set of first segments is received. The method determines whether to switch from using the first protocol to a second protocol in the playback session based on receiving the set of first segments. When switching to the second protocol, the method sends a second request in the playback session, wherein the second request indicates the second protocol is to be used to send a second segment of the video.

Abstract: Disclosed are a vehicle power transmission system and a vehicle power system. The vehicle power transmission system includes two motor output shafts, two power output shafts and two transmission mechanisms respectively connected between the two motor output shafts and the two power output shafts correspondingly. Each transmission mechanism includes a motor output gear, a power output gear and a middle transmission gear structure. The motor output gear is arranged on a motor output shaft, and the power output gear is arranged on a power output shaft. The middle transmission gear structure is in transmission connection with the motor output gear and the power output gear. The two power output shafts extend in a first direction, along the first direction, projections of the two motor output shafts are at least partially overlapped and/or projections of the two transmission mechanisms are at least partially overlapped.

Abstract: An impedance-tuned microphone tunnel for an electronic device is disclosed. The impedance-tuned microphone tunnel includes a ring-like structure having a central opening positioned within a microphone tunnel of an electronic device. The central opening of the ring-like structure has a diameter that is smaller than diameters of other central openings within the microphone tunnel. The ring-like structure may be used to tune an impedance of the microphone tunnel by varying the diameter of the central opening. In this way, the impedance of the microphone tunnel may be tuned to a frequency response target to reduce a resonant peak of the microphone tunnel. The ring-like structure may be coated with a non-stick material, such as with polyethylene terephthalate (PET), biaxially orientated polyethylene terephthalate (BoPET), polyimide (PI), and the like.

Abstract: The present disclosure provides a method of treating cancer in a subject. The method including administering to the subject: a) a therapeutically effective amount of a compound of formula (I); and b) a therapeutically effective amount of sotorasib, wherein the compound of formula (I) is represented by (I), or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, conformational isomer, tautomer, or a combination thereof. In particular, the present disclosure provides a method of treating a solid tumor (e.g., an advanced or metastatic non-small cell lung cancer) with a therapeutically effective amount of a compound of formula (10b) (i.e., 6-((3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(Ra)-(2,3-dichlorophenyl)-2,5-dimethylpyrimidin-4(3H)-one) in combination with sotorasib in a subject, wherein the subject has one or more mutations in KRAS, such as KRAS G12C.